AccScience Publishing / EJMO / Online First / DOI: 10.36922/EJMO026270320
Cite this article
2
Download
74
Views
Related Info Links
More by Authors Links
Journal Browser
Volume | Year
Issue
Search
News and Announcements
View All
ORIGINAL RESEARCH ARTICLE

Comparison of transrectal ultrasonographic and color Doppler features of benign prostatic hyperplasia and prostate cancer in older men

Ming Jin1,2† Baoding Shan3† Guangming Jin1*
Show Less
1 Department of Ultrasound Medicine, Affiliated Hospital of Yanbian University (Yanbian Hospital), Yanji, Jilin , China
2 Department of Spinal Surgery, Affiliated Hospital of Yanbian University (Yanbian Hospital), Yanji, Jilin , China
3 Outpatient Ultrasound Department, Yingkou Central Hospital, Yingkou, Liaoning , China
†These authors contributed equally to this work.
Received: 30 June 2026 | Revised: 16 August 2026 | Accepted: 1 September 2026 | Published online: 14 September 2026
© 2026 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution -Noncommercial 4.0 International License (CC-by the license) ( https://creativecommons.org/licenses/by-nc/4.0/ )
Abstract

Introduction: Benign prostatic hyperplasia (BPH) and prostate cancer (PCa) are prevalent in elderly men, yet differentiation using two-dimensional transrectal ultrasound (TRUS) remains challenging.

Objective: To compare grayscale TRUS features, color Doppler flow imaging (CDFI), and hemodynamic parameters between BPH and PCa in older men.

Methods: A total of 228 patients (132 BPH, 96 PCa) underwent TRUS from January 2022 to December 2023 at the Department of Urology at the Affiliated Hospital of Yanbian University. Two-dimensional characteristics, CDFI flow distribution, and hemodynamic parameters—including systolic blood flow velocity (Vs), diastolic blood flow velocity (Vd), and resistive index (RI)—were recorded and compared. Receiver operating characteristic (ROC) curves assessed diagnostic performance.

Results: BPH nodules were typically round/oval and located in the transition zone, whereas PCa lesions were predominantly irregular and situated in the peripheral zone. Echogenicity types differed significantly (p = 0.013), with hypoechoic nodules more frequent in PCa (43.8% vs. 3.7%). Pulsed Doppler measurements showed higher Vs, Vd, and RI values in the PCa group than in the BPH group (all p < 0.01). ROC analysis yielded areas under the curves of 0.914, 0.835, and 0.792 for Vs, Vd, and RI, respectively. PCa vessels were thicker, more tortuous, and branched, mainly in the peripheral zone, whereas BPH vessels were thinner and straighter, predominantly in the transition zone.

Conclusion: TRUS with CDFI and hemodynamic assessment may provide useful supplementary information for differentiating BPH from PCa. However, histopathological confirmation via prostate biopsy remains the definitive standard.

Keywords
Prostatic hyperplasia
Prostate cancer
Transrectal ultrasound
Color Doppler
Blood flow dynamics
Funding
This research was funded by the Natural Science Foundation of Jilin Province (YDZJ202201ZYTS204).
Conflict of interest
The authors declare they have no competing interests.
References
  1. Xiang X, Wang Y. Zhongguo renkou laolinghua xianzhuang, tedian, yuanyin ji duice [Current situation, characteristics, causes and countermeasures of population aging in China]. Chin J Gerontol. 2021;41(18):4149-4152. [In Chinese] doi: 10.3969/j.issn.1005-9202.2021.18.072
  2. He J, Chen WQ, Li N, et al. Zhongguo qianliexian'ai shaicha yu zao zhen zao zhi zhinan (2022, Beijing) [China guideline for the screening and early detection of prostate cancer (2022, Beijing)]. Chin J Oncol. 2022;44(1):29-53. [In Chinese] doi: 10.3760/cma.j.cn112152-20211226-00975
  3. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249. doi: 10.3322/caac.21660
  4. Gandaglia G, Leni R, Bray F, et al. Epidemiology and prevention of prostate cancer. Eur Urol Oncol. 2021;4(6):877-892. doi: 10.1016/j.euo.2021.09.006
  5. Panzone J, Byler T, Bratslavsky G, Goldberg H. Transrectal ultrasound in prostate cancer: current utilization, integration with mpMRI, HIFU and other emerging applications. Cancer Manag Res. 2022;14:1209-1228. doi: 10.2147/CMAR.S265058
  6. Park BK. Added values of transrectal ultrasonography to magnetic resonance imaging in characterizing prostate cancer: A narrative review. Precis Future Med. 2023;7(3):131-135. doi: 10.23838/pfm.2023.00107
  7. Thangarasu M, Jayaprakash SP, Selvaraj N, et al. A prospective study on the efficacy of cognitive targeted transrectal ultrasound prostate biopsy in diagnosing clinically significant prostate cancer. Res Rep Urol. 2021;13:207-213. doi: 10.2147/RRU.S300868
  8. Postema A, Mischi M, de la Rosette J, Wijkstra H. Multiparametric ultrasound in the detection of prostate cancer: a systematic review. World J Urol. 2015;33(11):1651-1659. doi: 10.1007/s00345-015-1523-6
  9. Ashi K, Kirkham B, Chauhan A, Schultz SM, Brake BJ, Sehgal CM. Quantitative colour Doppler and greyscale ultrasound for evaluating prostate cancer. Ultrasound. 2021;29(2):106-111. doi: 10.1177/1742271X20952825
  10. Jafari E, Ahmadzadehfar H, Dadgar H, Assadi M. An overview on prostate-specific membrane antigen uptake in malignancies other than prostate cancer: A pictorial essay. World J Nucl Med. 2020;19(3):260-265. doi: 10.4103/wjnm.WJNM_78_19
  11. Zhong K, Luo W, Li N, et al. CDK12 regulates angiogenesis of advanced prostate cancer by IGFBP3. Int J Oncol. 2024;64(2):20. doi: 10.3892/ijo.2024.5608
  12. Chen T, Wang F, Chen H, et al. Multiparametric transrectal ultrasound for the diagnosis of peripheral zone prostate cancer and clinically significant prostate cancer: novel scoring systems. BMC Urol. 2022;22(1):64. doi: 10.1186/s12894-022-01013-8
  13. Yu J, Jin XZ, Tian SR, Sinha A, Jin GM. Jing zhichang chaosheng jiancha qianliexian zengshengzheng de youshi ji qi teyixing canshu de linchuang jiazhi [Advantages of transrectal ultrasonography in the diagnosis of benign prostatic hyperplasia and the clinical value of its specific parameters]. China Mod Doct. 2022;60(1):129-132. [In Chinese] doi: 10.3969/j.issn.1673-9701.2021.01.035
  14. Yin MJ, Jin XZ, Sinha A, Jin GM. Yanbian diqu liushou laoren liangxing qianliexian zengshengzheng weixian yinsu xiangguanxing yanjiu [Risk factors of benign prostatic hyperplasia in the left-behind elderly in Yanbian area]. China Mod Doct. 2020;58(35):92-95. [In Chinese] doi: 10.3969/j.issn.1673-9701.2020.35.023
  15. Kuru TH, Fütterer JJ, Schiffmann J, et al. Transrectal Ultrasound (US), Contrast-enhanced US, Real-time Elastography, HistoScanning, Magnetic Resonance Imaging (MRI), and MRI-US Fusion Biopsy in the Diagnosis of Prostate Cancer. Eur Urol Focus. 2015;1(2):117-126. doi: 10.1016/j.euf.2015.06.003
  16. Salloum O, Serboiu C, Taciuc IA, et al. Current Approach to Complications and Difficulties during Transrectal Ultrasound-Guided Prostate Biopsies. J Clin Med. 2024;13(2):487. doi: 10.3390/jcm13020487
  17. Gao Y, Liao XH, Lu L, et al. Contrast-enhanced transrectal ultrasonography for the detection of diffuse prostate cancer. Clin Radiol. 2016;71(3):258-264. doi: 10.1016/j.crad.2015.11.013
  18. Fu S, Tang Y, Tan S, Zhao Y, Cui L. Diagnostic value of transrectal shear wave elastography for prostate cancer detection in peripheral zone: comparison with magnetic resonance imaging. J Endourol. 2020;34(5):558-566. doi: 10.1089/end.2019.0902
  19. Osorio C, Costa WS, Gallo C, Sampaio F. Expression of stromal elements of prostatic adenocarcinoma in different Gleason scores. Acta Cir Bras. 2019;34(10):e201901005. doi: 10.1590/s0102-865020190100000005
  20. Schmid HP, Hechelhammer L, Müllhaupt G. Re: Early Results of Unilateral Prostatic Artery Embolization as a Focal Therapy in Patients with Prostate Cancer Under Active Surveillance: Cancer Prostate Embolisation, a Pilot Study. Eur Urol. 2022;81(1):121-122. doi: 10.1016/j.eururo.2021.10.027
  21. Xu ZW, Zhou CG, Tian W, Shi HB, Liu S. Angiographic findings relevant to prostatic artery embolization in patients with prostate cancer. J Vasc Interv Radiol. 2020;31(6):899-902.e1. doi: 10.1016/j.jvir.2020.02.012
  22. Zeng S, Wu SQ, Chen C, et al. Performance characteristics of 3-D power Doppler ultrasound (3-D-PD) with the virtual organ computer-aided analysis (VOCAL) technique in the detection of prostate cancer. Ultrasound Med Biol. 2022;48(1):91-97. doi: 10.1016/j.ultrasmedbio.2021.09.016
  23. Sun Y, Fang J, Shi Y, et al. Machine learning based on radiomics features combining B-mode transrectal ultrasound and contrast-enhanced ultrasound to improve peripheral zone prostate cancer detection. Abdom Radiol (NY). 2023;49(1):141-150. doi: 10.1007/s00261-023-04050-5
  24. Nong W, Huang Q, Gao Y. Development and validation of a nomogram for predicting prostate cancer based on combining contrast-enhanced transrectal ultrasound and biparametric MRI imaging. Front Oncol. 2023;13:1275773. doi: 10.3389/fonc.2023.1275773
  25. Ma ZX, Zhao YP, Nie F. Chaosheng zaoying dingliang guanzhu fenxi zai qianliexian liang-exing bingbian zhong de jiazhi [Value of the quantitative perfusion analysis of contrast-enhanced ultrasound in benign and malignant prostate diseases]. J Lanzhou Univ (Med Sci). 2023;49(11):67-71. [In Chinese] doi: 10.13885/j.issn.1000-2812.2023.11.010
  26. Keskin ET, Kaplanoglu V, Senocak C, Basar H, Bozkurt OF. Transrectal shear wave elastography for detection of prostate cancer. Urologia. 2023;90(2):230-235. doi: 10.1177/03915603231167650
  27. Tyloch DY, Tyloch JF, Adamowicz J, et al. Comparison of strain and shear wave elastography in prostate cancer detection. Ultrasound Med Biol. 2023;49(3):889-900. doi: 10.1016/j.ultrasmedbio.2022.11.015
  28. Jeon SS, Kim CK, Park SY, et al. The utility of two-dimensional shear wave elastography for predicting prostate cancer: a preliminary study. Ultrasonography. 2023;42(3):400-409. doi: 10.14366/usg.22202
  29. Avolio PP, Lughezzani G, Anidjar M, et al. The diagnostic accuracy of micro-ultrasound for prostate cancer diagnosis: a review. World J Urol. 2023;41(11):3267-3276. doi: 10.1007/s00345-023-04521-w
  30. Maffei D, Fasulo V, Avolio PP, et al. Diagnostic performance of microUltrasound at MRI-guided confirmatory biopsy in patients under active surveillance for low-risk prostate cancer. Prostate. 2023;83(9):886-895. doi: 10.1002/pros.24532
  31. Dias AB, Ghai S. Prostate Cancer Diagnosis with Micro-ultrasound: What We Know now and New Horizons. Radiol Clin North Am. 2024;62(1):189-197. doi: 10.1016/j.rcl.2023.06.014
  32. Okedere TA, Asaleye CM, Ayoola OO, et al. Correlation of Doppler ultrasound resistive index in the prostatic gland with severity of male lower urinary tract symptoms, prostate volume, and concomitant diabetes mellitus. Cent Eur J Urol. 2023;76(3):199-206. doi: 10.5173/ceju.2023.47
  33. Onigbinde SO, Asaleye CM, Salako AA, Idowu BM, Onigbinde AO, Laoye A. The effect of systemic hypertension on prostatic artery resistive indices in patients with benign prostate enlargement. Prostate Int. 2023;11(1):46-50. doi: 10.1016/j.prnil.2022.09.001
  34. Guo YW, Su KB, Lu MH, Liu XP. Incorporation of trans-rectal color Doppler flow imaging and risk-stratification nomogram reduce unnecessary prostate biopsies in suspected prostate cancer patients: a bi-centered retrospective validation study. BMC Urol. 2023;23(1):81. doi: 10.1186/s12894-023-01245-2
  35. Li H, Yu WL, Wu ML. Jing zhichang jianqiebo tanxingchengxiang dui cunzai xia niaolu zhengzhuang de qianliexian bingbian liang-exing de jianbie zhenduan jiazhi ji qi yingxiang yinsu fenxi [Value of transrectal shear-wave elastography in differential diagnosis of benign and malignant prostate lesions with lower urinary tract symptoms and factors related to severity of such symptoms]. Chin J Med Ultrasound (Electronic Edition). 2023;20(11):1193-1198. [In Chinese] doi: 10.3877/cma.j.issn.2096-1537.2023.11.014
  36. Pepe P, Pepe L, Fiorentino V, Curduman M, Fraggetta F. Multiparametric MRI targeted prostate biopsy: When omit systematic biopsy? Arch Ital Urol Androl. 2024;96(4):12992. doi: 10.4081/aiua.2024.12992
  37. Xu G, Li JH, Xiang LH, et al. Transrectal ultrasound examination of prostate cancer guided by fusion imaging of multiparametric MRI and TRUS: avoiding unnecessary mpMRI-guided targeted biopsy. Asian J Androl. 2023;25(3):410-415. doi: 10.4103/aja202276
  38. Agrotis G, Tsougos I, Oikonomou A, et al. Combination of fusion guided multiparametric MRI-transrectal US with systematic biopsy of the prostate for the detection of clinically significant prostate cancer: A prospective single-center study. J Clin Ultrasound. 2023;51(6):1101-1111. doi: 10.1002/jcu.23497
  39. Zhang ML, Liu YZ, Yao JC, et al. Value of machine learning-based transrectal multimodal ultrasound combined with PSA-related indicators in the diagnosis of clinically significant prostate cancer. Front Endocrinol (Lausanne). 2023;14:1137322. doi: 10.3389/fendo.2023.1137322
  40. Klotz L, Chin J, Black PC, et al. Comparison of multiparametric magnetic resonance imaging-targeted biopsy with systematic transrectal ultrasonography biopsy for biopsy-naive men at risk for prostate cancer: a phase 3 randomized clinical trial. JAMA Oncol. 2021;7(4):534-542. doi: 10.1001/jamaoncol.2020.7589
  41. Matuszczak M, Schalken JA, Salagierski M. Prostate Cancer Liquid Biopsy Biomarkers' Clinical Utility in Diagnosis and Prognosis. Cancers. 2021;13(13):3373. doi: 10.3390/cancers13133373
  42. Jawli A, Nabi G, Huang ZH. The performance of different parametric ultrasounds in prostate cancer diagnosis: correlation with radical prostatectomy specimens. Cancers. 2024;16(8):1502. doi: 10.3390/cancers16081502
Share
Back to top
Eurasian Journal of Medicine and Oncology, Electronic ISSN: 2587-196X Print ISSN: 2587-2400, Published by AccScience Publishing